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Abstract
Cyclin D1 is an important molecular driver of human breast cancer but better understanding of
its oncogenic mechanisms is needed, especially to enhance efforts in targeted therapeutics.
Currently, pharmaceutical initiatives to inhibit cyclin D1 are focused on the catalytic component
since the transforming capacity is thought to reside in the cyclin D1/CDK activity. We initiated
the following study to directly test the oncogenic potential of catalytically inactive cyclin D1 in
an in vivo mouse model that is relevant to breast cancer. Herein, transduction of cyclin D1-/-
mouse embryonic  fibroblasts  (MEFs)  with  the  kinase  dead KE mutant  of  cyclin  D1 led  to
aneuploidy,  abnormalities  in  mitotic  spindle  formation,  autosome  amplification,  and
chromosomal  instability  (CIN)  by gene expression profiling.  Acute transgenic  expression of
either cyclin D1WT or cyclin D1KE in the mammary gland was sufficient to induce a high CIN score
within 7 days. Sustained expression of cyclin D1KE  induced mammary adenocarcinoma with
similar kinetics to that of the wild-type cyclin D1. ChIP-Seq studies demonstrated recruitment of
cyclin D1WT and cyclin D1KE to the genes governing CIN. We conclude that the CDK-activating
function of cyclin D1 is not necessary to induce either chromosomal instability or mammary
tumorigenesis.
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